Download Files:
(S)-LY3177833 (hydrate)
$250 – $2,400
Products Details
Product Description
– (S)-LY3177833 ((S)-Example 2) hydrate is an orally active CDC7 kinase inhibitor. (S)-LY3177833 hydrate shows broad in vitro anticancer activity[1].
Web ID
– HY-143430A
Shipping
– Room temperature
Applications
– Cancer-Kinase/protease
Molecular Formula
– C16H14FN5O2
References
– [1]Robert Dean Dally, et al. CDC7 Inhibitors. WO2014143601 A1.
CAS Number
– 2733342-93-1
Molecular Weight
– 327.31
SMILES
– O=C1N[C@](C)(C2=NC=NC=C2F)C3=C1C=C(C4=CNN=C4)C=C3.O
Clinical Information
– No Development Reported
Research Area
– Cancer
Solubility
– 10 mM in DMSO
Target
– CDK
Isoform
– CDC
Pathway
– Cell Cycle/DNA Damage
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
